What is a stock summary page? Click here for an overview.
Business Description
Kangstem Biotech Co Ltd
ISIN : KR7217730001
Compare
Compare
Traded in other countries / regions
217730.Korea Index Membership
KOSDAQ Composite Index IPO Date
2015-12-21Description
Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.16 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | -2.18 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.38 | |||||
| Beneish M-Score | -1.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -30.2 | |||||
| 3-Year EBITDA Growth Rate | 52.2 | |||||
| 3-Year EPS without NRI Growth Rate | 45.3 | |||||
| 3-Year FCF Growth Rate | 21 | |||||
| 3-Year Book Growth Rate | -20.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.59 | |||||
| 9-Day RSI | 61.96 | |||||
| 14-Day RSI | 60.39 | |||||
| 3-1 Month Momentum % | 18.72 | |||||
| 6-1 Month Momentum % | 12.88 | |||||
| 12-1 Month Momentum % | -18.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.69 | |||||
| Quick Ratio | 3.58 | |||||
| Cash Ratio | 2.36 | |||||
| Days Inventory | 53.37 | |||||
| Days Sales Outstanding | 32.81 | |||||
| Days Payable | 24.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.7 | |||||
| Shareholder Yield % | 2.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.17 | |||||
| Operating Margin % | -163.31 | |||||
| Net Margin % | -85.2 | |||||
| FCF Margin % | -208.8 | |||||
| ROE % | -17.06 | |||||
| ROA % | -11.51 | |||||
| ROIC % | -33.77 | |||||
| 3-Year ROIIC % | -40.78 | |||||
| ROC (Joel Greenblatt) % | -30.58 | |||||
| ROCE % | -13.37 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 14.76 | |||||
| PB Ratio | 3.16 | |||||
| Price-to-Tangible-Book | 3.23 | |||||
| EV-to-EBIT | -17.76 | |||||
| EV-to-EBITDA | -32.52 | |||||
| EV-to-Revenue | 13.48 | |||||
| EV-to-FCF | -6.43 | |||||
| Price-to-GF-Value | 2.21 | |||||
| Price-to-Net-Current-Asset-Value | 8.66 | |||||
| Price-to-Net-Cash | 24.94 | |||||
| Earnings Yield (Greenblatt) % | -5.63 | |||||
| FCF Yield % | -14.37 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kangstem Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 9,377.836 | ||
| EPS (TTM) (â‚©) | -136 | ||
| Beta | 1.32 | ||
| 3-Year Sharpe Ratio | 0.16 | ||
| 3-Year Sortino Ratio | 0.24 | ||
| Volatility % | 74.1 | ||
| 14-Day RSI | 60.39 | ||
| 14-Day ATR (â‚©) | 113.976702 | ||
| 20-Day SMA (â‚©) | 2303.5 | ||
| 12-1 Month Momentum % | -18.99 | ||
| 52-Week Range (â‚©) | 1388 - 3920 | ||
| Shares Outstanding (Mil) | 56.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kangstem Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kangstem Biotech Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kangstem Biotech Co Ltd Frequently Asked Questions
What is Kangstem Biotech Co Ltd(XKRX:217730)'s stock price today?
The current price of XKRX:217730 is â‚©2430.00. The 52 week high of XKRX:217730 is â‚©3920.00 and 52 week low is â‚©1388.00.
When is next earnings date of Kangstem Biotech Co Ltd(XKRX:217730)?
The next earnings date of Kangstem Biotech Co Ltd(XKRX:217730) is .
Does Kangstem Biotech Co Ltd(XKRX:217730) pay dividends? If so, how much?
Kangstem Biotech Co Ltd(XKRX:217730) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers